Local recurrence after mastectomy or breast-conserving surgery and radiation

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Local recurrence after initial treatment for stage I/II invasive breast cancer occurs in 10-15% of patients.
• Standard management differs based on recurrence location: salvage mastectomy for ipsilateral breast tumor recurrence post-breast-conserving surgery and radiation, versus local excision and radiation for chest wall recurrence post-mastectomy.

Purpose of the Study:

• To review the management and prognostic factors for isolated local recurrence of invasive breast cancer.
• To discuss the role of systemic therapy in patients with isolated local relapse.

Main Methods:

• Review of existing literature on local recurrence of invasive breast cancer.
• Analysis of prognostic factors influencing patient outcomes.
• Discussion of treatment strategies including surgery, radiation, and systemic therapy.

Main Results:

• Isolated local recurrence is a known complication of breast cancer treatment.
• The interval between initial treatment and local recurrence is a critical prognostic factor.
• Favorable prognostic factors combined with a prolonged interval can predict favorable 5-year survival rates (>=70%).

Conclusions:

• Systemic therapy (chemotherapy and/or hormonal therapy) should be considered for most patients with isolated local relapse due to the risk of distant metastasis.
• Local recurrence does not invariably predict distant disease, especially when the interval to recurrence is prolonged.
• Prognosis is significantly influenced by the timing of recurrence and other favorable characteristics.